Effect of iontophoresis and switching iontophoresis on skin accumulation of ketoprofen

Biological and Pharmaceutical Bulletin

Volumn 31, Issue 3, 2008, Pages 487-492

  Okuno, Motonori ^a   Takahashi, Yuri ^a   Isowa, Koichi ^b   Machida, Yoshiharu ^a  

^a HOSHI UNIVERSITY   (Japan)

^b Japan Biological Science Inc   (Japan)

Author keywords

Ketoprofen; Skin accumulation; Skin hydration; Switching iontophoresis

Indexed keywords

FLUORESCEIN; KETOPROFEN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; ELECTRODE; FLUORESCENCE; IONTOPHORESIS; MALE; NONHUMAN; RAT; SKIN ABSORPTION; SKIN IRRITATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; DIFFUSION CHAMBERS, CULTURE; ELECTRODES; FLUORESCEIN; FLUORESCENCE; IONTOPHORESIS; KETOPROFEN; MALE; RATS; RATS, WISTAR; SKIN; SKIN IRRITANCY TESTS;

EID: 41149141773     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.31.487     Document Type: Article

References (25)

1. Thysman S., Hanchard C., Preat V., J. Pharm. Pharmacol., 46, 725-730 (1994).
2. Mayes S., Ferrone M., Ann. Pharmacother., 40, 2178-2186 (2006).
3. Hayden B., Jockovich M. E., Murray T. G., Kralinger M. T., Voigt M., Hernandez E., Feuer W., Parel J. M., Invest. Ophthalmol. Vis. Sci., 47, 3717-3721 (2006).
4. Schuetz Y. B., Carrupt P. A., Naik A., Guy R. H., Kalia Y. N., Eur. J. Pharm. Sci., 29, 53-59 (2006).
5. Wong T. W., Chen C. H., Huang C. C., Lin C. D., Hui S. W., J. Controlled Release, 110, 557-565 (2006).
6. Tokudome Y., Sugibayashi K., J. Controlled Release, 95, 267-274 (2004).
7. Tezel A., Dokka S., Kelly S., Hardee G. E., Mitragotri S., Pharm. Res., 21, 2219-2225 (2004).
8. Terzo S. D., Behl C. R., Nash R. A., Pharm. Res., 6, 85-90 (1989).
9. Sims S. M., Higuchi W. I., Srinivasan V., Int. J. Pharm., 69, 109-121 (1991).
10. Hirvonen J., Guy R. H., J. Controlled Release, 50, 283-289 (1998).
11. Chaturvedula A., Joshi D. P., Anderson C., Morris R. L., Sembrowich W. L., Banga A. K., Int. J. Pharm., 297, 190-196 (2005).
12. Zakzewski C. A., Wasilewski J., Cawley P., Ford W., J. Controlled Release, 50, 267-272 (1998).
13. Sintov A. C., Brandys-Sitton R., Int. J. Pharm., 316, 58-67 (2006).
14. Zempsky W. T., Sullivan J., Paulson D. M., Hoath S. B., Clin. Ther., 26, 1110-1119 (2004).
15. Ebihara M., Akiyama M., Ohnishi Y., Tajima S., Komata K., Mitsui Y., J. Dermatol. Sci., 32, 217-222 (2003).
16. Takehana J., Kato Y., Onishi H., Nagai T., Machida Y., STP Pharma. Sci., 13, 253-258 (2003).
17. Takahashi Y., Iwata M., Machida Y., Yakugaku Zasshi, 121, 161-166 (2001).
18. Tomohira Y., Machida Y., Onishi H., Nagai T., Int. J. Pharm., 155, 231-239 (1997).
19. Ishikawa O., Kato Y., Onishi H., Nagai T., Machida Y., Int. J. Pharm., 249, 81-88 (2002).
20. Sotoishi N., Kato Y., Onishi H., Nagai T., Machida Y., J. Pharm. Sci. Technol. Jpn., 63, 20-28 (2003).
21. Tashiro Y., Kato Y., Hayakawa E., Ito K., Biol. Pharm. Bull., 23, 632-636 (2000).
22. Ayala-Bravo H. A., Quintanar-Guerrero D., Naik A., Kalia Y. N., Cornejo-Bravo J. M., Ganem-Quintanar A., Pharm. Res., 20, 1267-1273 (2003).
23. Pershing L. K., Corlett J., Jorgensen C., Antimicrob. Agents Chemother., 38, 90-95 (1994).
24. Pikal M. J., Shah S., Pharm. Res., 8, 365-369 (1991).
25. Burnette R. R., Ongpipattanakul B., J. Pharm. Sci., 77, 132-137 (1988).